Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Thursday, August 16, 2012 12:36:38 PM
As noted, unless you have inside information, you have no idea if they are in the process of duplicating the agreement which they had with U of Miami (without escape clause) for a bigger piece of the action or if they are engaged in partnership with a major pharmacological...which "research report" alluded to as possible fit and suitor Celgene.
Very misleading comments based on prior ability of company to get partner and possible discussions...we dont know what they are doing behind the scene.
With FDA "permission" to proceed, the question of what the SEC is looking at eliminates the substance of their technology....so must be other issues looking at ...no doubt complaints by shareholders of stock movement.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM